Carl Anthony Evans

Carl Anthony Evans is a declared insider of CNS Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 8 March 2022 and the latest from 1 February 2024.

On the market, this insider has only ever bought: 1 purchase, €9,256 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. Since January 2024: 1 purchase and no sales on the market.

Most recently, on 6 February 2024, the filings show an open-market purchase worth €9,256 in CNS Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.